1 Abdul-Ghani MA, "What is the best predictor of future type 2 diabetes?" 30 : 1544-1548, 2007
2 Seuring T, "The economic costs of type 2 diabetes: a global systematic review" 33 : 811-831, 2015
3 Shah RV, "Statins and risk of new-onset diabetes mellitus" 126 : e282-e284, 2012
4 Chogtu B, "Statin use and risk of diabetes mellitus" 6 : 352-357, 2015
5 Warram JH, "Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents" 113 : 909-915, 1990
6 Shimada A, "Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association" 15 : 57-, 2016
7 Poitout V, "Regulation of the insulin gene by glucose and fatty acids" 136 : 873-876, 2006
8 Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes" 36 : 232-240, 2005
9 Tchernof A, "Pathophysiology of human visceral obesity: an update" 93 : 359-404, 2013
10 Verges B, "Pathophysiology of diabetic dyslipidaemia: where are we?" 58 : 886-899, 2015
1 Abdul-Ghani MA, "What is the best predictor of future type 2 diabetes?" 30 : 1544-1548, 2007
2 Seuring T, "The economic costs of type 2 diabetes: a global systematic review" 33 : 811-831, 2015
3 Shah RV, "Statins and risk of new-onset diabetes mellitus" 126 : e282-e284, 2012
4 Chogtu B, "Statin use and risk of diabetes mellitus" 6 : 352-357, 2015
5 Warram JH, "Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents" 113 : 909-915, 1990
6 Shimada A, "Serum CETP status is independently associated with reduction rates in LDL-C in pitavastatin-treated diabetic patients and possible involvement of LXR in its association" 15 : 57-, 2016
7 Poitout V, "Regulation of the insulin gene by glucose and fatty acids" 136 : 873-876, 2006
8 Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes" 36 : 232-240, 2005
9 Tchernof A, "Pathophysiology of human visceral obesity: an update" 93 : 359-404, 2013
10 Verges B, "Pathophysiology of diabetic dyslipidaemia: where are we?" 58 : 886-899, 2015
11 Hagman DK, "Palmitate inhibits insulin gene expression by altering PDX-1 nuclear localization and reducing MafA expression in isolated rat islets of Langerhans" 280 : 32413-32418, 2005
12 Roberts CK, "Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training" 3 : 1-58, 2013
13 Rhee EJ, "Metabolic health is a more important determinant for diabetes development than simple obesity: a 4-year retrospective longitudinal study" 9 : e98369-, 2014
14 Shimabukuro M, "Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression" 273 : 32487-32490, 1998
15 Kruit JK, "Islet cholesterol accumulation due to loss of ABCA1 leads to impaired exocytosis of insulin granules" 60 : 3186-3196, 2011
16 Sommariva D, "Interrelationships between body mass and lipid and lipoprotein triglycerides and cholesterol in obese women" 16 : 481-488, 1986
17 Cunha DA, "Initiation and execution of lipotoxic ER stress in pancreatic beta-cells" 121 : 2308-2318, 2008
18 Rhee EJ, "Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: a nationwide population-based study" 12 : e0176615-, 2017
19 Dotevall A, "Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study" 21 : 615-622, 2004
20 Lillioja S, "Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians" 318 : 1217-1225, 1988
21 Shaw JE, "Global estimates of the prevalence of diabetes for 2010 and 2030" 87 : 4-14, 2010
22 Ginsberg HN, "Effects of statins on triglyceride metabolism" 81 : 32B-35B, 1998
23 Bardini G, "Dyslipidemia and diabetes: reciprocal impact of impaired lipid metabolism and beta-cell dysfunction on micro- and macrovascular complications" 9 : 82-93, 2012
24 Hao M, "Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction" 56 : 2328-2338, 2007
25 Muacevic-Katanec D, "Diabetic dyslipidemia or 'diabetes lipidus'?" 9 : 341-348, 2011
26 Schwartz KL, "Correlation of same-visit HbA1c test with laboratorybased measurements: a MetroNet study" 6 : 28-, 2005
27 Sandhofer A, "Cholesteryl ester transfer protein in metabolic syndrome" 14 : 812-818, 2006
28 Tirosh A, "Changes in triglyceride levels over time and risk of type 2 diabetes in young men" 31 : 2032-2037, 2008
29 Seo MH, "Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study" 96 : E2050-E2054, 2011
30 Gutch M, "Assessment of insulin sensitivity/resistance" 19 : 160-164, 2015
31 Marathe PH, "American Diabetes Association standards of medical care in diabetes 2017" 9 : 320-324, 2017
32 Galic S, "Adipose tissue as an endocrine organ" 316 : 129-139, 2010
33 Ohn JH, "10-Year trajectory of ${\beta}$-cell function and insulin sensitivity in the development of type 2 diabetes: a communitybased prospective cohort study" 4 : 27-34, 2016